Form 8-K - Current report:
SEC Accession No. 0001104659-25-098546
Filing Date
2025-10-10
Accepted
2025-10-10 08:20:32
Documents
12
Period of Report
2025-10-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2528470d1_8k.htm   iXBRL 8-K 27569
  Complete submission text file 0001104659-25-098546.txt   194753

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zura-20251008.xsd EX-101.SCH 3011
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20251008_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20251008_pre.xml EX-101.PRE 22356
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2528470d1_8k_htm.xml XML 3804
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 251386319
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)